ELAN
Elanco Animal Health, Inc.
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · US
$22.42
−1.41%Forward multiples
Based on analyst estimates
- P/E forward
- 18.77x
- P/E 2026E
- 19.75x
- P/E 2027E
- 17.55x
- P/E 2028E
- 15.49x
- P/S forward
- 2.13x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.70x
- Price / sales
- 2.23x
- Price / cash flow
- 18.15x
Enterprise value
- Enterprise value
- $14.6B
- EV / sales
- 2.91x
- EV / EBITDA
- 18.85x
- EV / EBIT
- 31.58x
- Market cap
- $11.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026